on Wednesday flagged promising late-stage trial success for its new Cagrilinitide weight problems therapy, since the Danish pharmaceutical big seeks a following-technology option to its blockbuster Wegovy fat-decline drug.→ Designed for balance: Purely natural amylin breaks down promptly in your body, which restrictions its therapeutic opportunit